Nashville Democratic Rep. Aftyn Behn has asked Tennessee’s Attorney General to investigate CVS over potentially deceptive ...

State lawmakers push legislation to bar pharmacy benefit managers from owning retail or mail-order licenses; The push has momentum in Tennessee, with a House committee ...

The announced closing of Martella’s Penn Laurel Pharmacy in Central City ramps up the urgency for the local drug-store ...

CVS owns health insurer Aetna and pharmacy benefit manager Caremark, allowing it to control how medications are priced, ...

Customers in Central City are voicing frustration and sadness as Martella’s Pharmacy prepares to close its Penn-Laurel ...

Bernstein Litowitz Berger & Grossmann LLP (BLB&G) announces the filing of a class action against leading pharmacy benefits manager CaremarkPCS Health, LLC along with its corporate parent, CVS Health ...

Express Scripts agreed to pay a $1.5 million administrative penalty and implement corrective actions following an investigation by the West Virginia Offices of the Insurance Commissioner. Between May ...

The MarketWatch News Department was not involved in the creation of this content. Nation's largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

Today, Bernstein Litowitz Berger & Grossmann LLP (BLB&G) announces the filing of a class action against Express Scripts – the nation’s largest Pharmacy Benefits Manager (PBM) – and its parent ...

On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.